Pierré A - Search Results

1

Synthesis of N,N'-disubstituted 3-aminobenzo[c] and [d]azepin-2-ones as potent and specific farnesyl transferase inhibitors.

Le Diguarher T, Ortuno JC, Shanks D, Guilbaud N, Pierré A, Raimbaud E, Fauchère JL, Hickman JA, Tucker GC, Casara PJ. Le Diguarher T, et al. Among authors: pierre a. Bioorg Med Chem Lett. 2004 Feb 9;14(3):767-71. doi: 10.1016/j.bmcl.2003.11.013. Bioorg Med Chem Lett. 2004. PMID: 14741286

2

Parallel liquid synthesis of N,N'-Disubstituted 3-amino azepin-2-ones as potent and specific farnesyl transferase inhibitors.

Le Diguarher T, Ortuno JC, Dorey G, Shanks D, Guilbaud N, Pierré A, Fauchère JL, Hickman JA, Tucker GC, Casara PJ. Le Diguarher T, et al. Among authors: pierre a. Bioorg Med Chem. 2003 Jul 17;11(14):3193-204. doi: 10.1016/s0968-0896(03)00218-9. Bioorg Med Chem. 2003. PMID: 12818682

3

Synthesis and pharmacological evaluation of novel non-lactone analogues of camptothecin.

Hautefaye P, Cimetière B, Pierré A, Léonce S, Hickman J, Laine W, Bailly C, Lavielle G. Hautefaye P, et al. Among authors: pierre a. Bioorg Med Chem Lett. 2003 Aug 18;13(16):2731-5. doi: 10.1016/s0960-894x(03)00534-1. Bioorg Med Chem Lett. 2003. PMID: 12873503

4

Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.

Le Diguarher T, Chollet AM, Bertrand M, Hennig P, Raimbaud E, Sabatini M, Guilbaud N, Pierré A, Tucker GC, Casara P. Le Diguarher T, et al. Among authors: pierre a. J Med Chem. 2003 Aug 28;46(18):3840-52. doi: 10.1021/jm0307638. J Med Chem. 2003. PMID: 12930146

5

Novel bicyclic oxazolone derivatives as anti-angiogenic agents.

Perron-Sierra FM, Pierré A, Burbridge M, Guilbaud N. Perron-Sierra FM, et al. Among authors: pierre a. Bioorg Med Chem Lett. 2002 Jun 3;12(11):1463-6. doi: 10.1016/s0960-894x(02)00197-x. Bioorg Med Chem Lett. 2002. PMID: 12031320

6

General synthesis of alpha-substituted 3-bisaryloxy propionic acid derivatives as specific MMP inhibitors.

Chollet AM, Le Diguarher T, Murray L, Bertrand M, Tucker GC, Sabatini M, Pierré A, Atassi G, Bonnet J, Casara P. Chollet AM, et al. Among authors: pierre a. Bioorg Med Chem Lett. 2001 Feb 12;11(3):295-9. doi: 10.1016/s0960-894x(00)00646-6. Bioorg Med Chem Lett. 2001. PMID: 11212095

7

Controlled exploration of structural databases: the case of farnesyl transferase inhibitors.

Tizot A, Tucker GC, Pierré A, Hickman J, Goldstein S. Tizot A, et al. Among authors: pierre a. Med Chem. 2009 May;5(3):208-15. doi: 10.2174/157340609788185891. Med Chem. 2009. PMID: 19442210

8

Cytotoxic and antitumoral properties in a series of new, ring D modified, olivacine analogues.

Guillonneau C, Nault A, Raimbaud E, Léonce S, Kraus-Berthier L, Pierré A, Goldstein S. Guillonneau C, et al. Among authors: pierre a. Bioorg Med Chem. 2005 Jan 3;13(1):175-84. doi: 10.1016/j.bmc.2004.09.047. Bioorg Med Chem. 2005. PMID: 15582462

9

Novel 5-azaindolocarbazoles as cytotoxic agents and Chk1 inhibitors.

Lefoix M, Coudert G, Routier S, Pfeiffer B, Caignard DH, Hickman J, Pierré A, Golsteyn RM, Léonce S, Bossard C, Mérour JY. Lefoix M, et al. Among authors: pierre a. Bioorg Med Chem. 2008 May 1;16(9):5303-21. doi: 10.1016/j.bmc.2008.02.086. Epub 2008 Mar 4. Bioorg Med Chem. 2008. PMID: 18342518

10

Synthesis and CHK1 inhibitory potency of Hymenialdisine analogues.

Parmentier JG, Portevin B, Golsteyn RM, Pierré A, Hickman J, Gloanec P, De Nanteuil G. Parmentier JG, et al. Among authors: pierre a. Bioorg Med Chem Lett. 2009 Feb 1;19(3):841-4. doi: 10.1016/j.bmcl.2008.12.001. Epub 2008 Dec 7. Bioorg Med Chem Lett. 2009. PMID: 19111462

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

475 results

Search Page